August 26, 2016 | Full Day Conference Agenda (subject to change)


Registration & Breakfast

8:00-9:00 am

Breakfast Keynote: Congresswoman Diana DeGette
Federal update on issues impacting the Life Science Industry including: 21st Century Cures, NIH Funding Packages and FDA

Discussion Session: Value Based Care
With increasing health care cost, focus needs to be given towards value-for-money, especially in the context of innovation. A multi-disciplinary approach towards development is important in order to demonstrate the value of innovation to physicians and patients. Demonstrating value will help ensure that innovative therapies should be seen as health care investment and not solely as an expense. The industry model has shifted so that success requires a clear and consistent focus on delivering differentiated value and performance. A panel of experts will explain the complexities, identify key value drivers and discuss the next generation of accountable care. 

Confirmed Panelists:
Kim Bimestefer, Chief Executive Officer, KBS Solutions 
Dr. Kenneth Faber, VP of Value and Resource Stewardship, Kaiser CPMG
Dorothy Bennett Hoffman, Corporate Affairs, Eli Lilly and Company
Huong Huang, Practice Director, Colorado Brain & Spine Institute
Moderated by: Simon Moss, Principal and Regional Healthcare Lead, North Highland


Networking Coffee Break & C Level Unplugged in Exhibit Hall
C Level Unplugged featuring: Charles Stacey, CEO, Accera
Interviewed by: Erik Reynolds, EY


Discussion Session: Partnering to Drive Innovation
Partnering means finding win-win solutions for both sides, while accelerating the delivery of transformational care to patients and bringing innovations to market.  This session will feature collaborations among partnering organizations that have achieved important steps toward ensuring access to faster cures and treatments to a reality.
Opening Remarks provided by: Don Elliman, Jr., Chancellor for the University of Colorado Anschutz Medical Campus
Special Remarks provided by: Governor John Hickenlooper
Confirmed Panelists:
Steven Lindseth, Founder and Entrepreneur, TripleTree Capital Partners
Carm Huntress, CEO, RxREVU
Steve Krein, Co-Founder & CEO, StartUp Health
Dr. Richard Zane, Chief Innovation Officer, UCHealth                         
Gil Peri, Senior Vice President, Chief Strategy Officer, Children's Hospital Colorado
Mike Biselli, President, Catalyst HTI
Moderated by: Kim Muller, Director of Technology Transfer, University of Colorado Anschutz Medical Campus

Noon - 1:00pm

Lunch Keynote:
Mike Genau, Senior Vice President and President, Americas Region, Medtronic


Networking Coffee Break & C Level Unplugged in Exhibit Hall 
C Level Unplugged featuring: Darren Dasburg, Vice President - Site Head, AstraZeneca/MedImmune
Interviewed by Erik Reynolds, EY

1:30- 2:30pm

Discussion Session: The Impact of Patient Input on R&D
In recent years, patient advocacy organizations have championed their causes to enhance the patient voice during the R&D process, focused on measuring how the FDA is or is not using new patient engagement tools. This session will explore the collaborative process through the roles of the patient, physician and industry. Featured in the sessions is the trailblazing advocacy group PPMD, Children’s Hospital and SomaLogic – a collaboration to bring new tools and therapies for Duchenne muscular Dystrophy and other diseases.
Confirmed Panelists:
Pat Furlong, Founding President & CEO, Parent Project Muscular Dystrophy (PPMD)
Robin Deterding, MD, Director of Breathing Institute at Children's Hospital Colorado, Chair, Children's Interstitial Lung Disease Network
Dr. Larry Gold, Chairman & Founder, SomaLogic
Dave Zook, Partner, Faegre Baker Daniels
Moderated by: Peter Schlueter, Ph.D., Faegre Baker Daniels


Venture Showcase
Three emerging life science companies present to a panel of investors for a $7,500 Venture Showcase cash prize. View the finalists


Discussion Session: The Future of Personalized Medicine: Gene Editing, Immunotherapy, Immuno-oncology Advances in personalized medicine have the ability to customize medical treatments by incorporating genetics, molecular profiles and clinical characteristics. Hear from leaders in the field of personalized medicine, from gene editing, diagnostics to immunotherapy and immuno-oncology, they will discuss how these approaches will impact the healthcare system and immensely influence treatment. 
Confirmed Speakers and Panelists:
Thomas Cech, Ph.D, Distinguished Professor, University of Colorado BioFrontiers Institute, Nobel Prize in Chemistry 1989
Vic Myer, Ph.D., Chief Technology Officer, EditasMed
Scott Bourgeois, MD, MBA, Associate Director Oncology Health Systems, Bristol-Meyers Squibb
Damon Hostin, Vice President, Precision Medicine, Catholic Health Initiatives

Venture Showcase winner to be announced at the conclusion of the Discussion Session!

5:00-6:00pm Closing Reception in Exhibit Hall